Showing 841 - 860 results of 226,747 for search '(( 5 ((nn decrease) OR (greater decrease)) ) OR ( a ((mean decrease) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 841
  2. 842
  3. 843
  4. 844
  5. 845
  6. 846

    Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
  7. 847

    YKL-40 levels decreased during the intensive anti-rheumatic treatment with a combination of csDMARDs. by Tuija Väänänen (4392307)

    Published 2017
    “…YKL-40 levels decreased significantly (p<0.001) during the first four weeks of treatment with csDMARDs; when infliximab (or placebo) was added to the treatment there was a minor further decrease (groups combined, p = 0.031) but no difference between placebo and infliximab treatment groups was found. …”
  8. 848
  9. 849
  10. 850

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. F. Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. …”
  11. 851
  12. 852
  13. 853
  14. 854

    The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical isolates in osteomyelitis by Mara J. Campbell (14579826)

    Published 2023
    “…We also showed that mutation of <i>sarA</i> results in a greater increase in protease production, and decrease in biofilm formation, than mutation of the loci encoding any of these other proteins. …”
  15. 855
  16. 856

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…Virus replication was further significantly inhibited in cultures containing a mixture of blocking antibodies to TNF, IL-6, and MCP-1 at a concentration of 2 µg/ml and 5 µg/ml (**, p<0.01). …”
  17. 857
  18. 858
  19. 859
  20. 860